Background of the study: Low molecular weight heparin is used for the prevention of blood clots and treatment of thromboembolism also myocardial infection. Subcutaneous administration of low molecular weight heparin may result pain and bruises.

Objective: The main objective of the study was to assess the effectiveness of novel technique on level of pain and bruise among patients receiving low molecular weight heparin in interventional and routine care group.

Research Methodology: A true experimental post test only control group design was used. As per the inclusion criteria 60 samples were selected by using purposive sampling and were divided into interventional and routine care group (each 30). Numerical rating scale was used to assess the severity of pain, bruise assessment scale was used to measure the bruise. For the interventional group novel technique of injecting low molecular weight heparin was received and routine care group participants received routine technique of low molecular weight heparin. The post test was assessed after the intervention, pain assessed immediately after the injection bruise measured after the 48 hours of injection.